Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes; HypertensionIntervention: Drug: amlodipine, hydralazine, terazosin or hydrochlorothiazideSponsor: Tulane University Health Sciences CenterRecruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Hydralazine | Norvasc | Research | Terazosin